Navigation Links
Royalty Pharma Statement Regarding Elan Proposal
Date:3/6/2013

products, with a portfolio of royalty interests in 37 approved and marketed products (including Abbott's Humira®, Johnson and Johnson's Remicade®, Merck's Januvia®, Gilead's Atripla®, Truvada®, and Emtriva®, Pfizer's Lyrica®, Amgen's Neupogen® and Neulasta®, and Genentech's Rituxan®) and 3 products pending approval. Royalty Pharma's product portfolio is well-diversified across biopharmaceutical products and treatment areas and consists of stable and long-dated assets. Royalty Pharma's portfolio includes royalties on 8 of the top 20 selling pharmaceutical and biotech drugs by expected worldwide 2016 sales[20], and 9 products with over US$1 billion in annual sales.

These entities have a longer than fifteen year history of providing value to holders of royalty interests, including a US$400 million purchase of 80 percent of Memorial Sloan-Kettering Cancer Center's Neupogen®/ Neulasta® royalty, a US$525 million joint acquisition with Gilead Sciences of Emory University's emtricitabine royalty interest, a US$650 million purchase of New York University's Remicade® royalty, a US$700 million acquisition of AstraZeneca's Humira® royalty, a US$700 million purchase of a portion of Northwestern University's Lyrica® royalty, a US$609 million acquisition of Astellas Pharma's patent estate and associated royalty stream relating to the use of dipeptidyl peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes including Januvia® and Janumet®, and most recently a US$761 million purchase of a portion of an interest in Biogen's Tecfidera (formerly BG-12) for the treatment of multiple sclerosis held by the former shareholders of Fumapharm AG. These entities are well diversified across biopharmaceutical products and treatment areas with unaudited revenue of US$1.39 billion for the 2012 financial year and unaudited EBITDA for the 2012 financial year of US$1.35 billion.

<
'/>"/>
SOURCE RP Management, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related biology technology :

1. PDL BioPharma Provides Third Quarter 2012 Royalty Revenue Guidance of $85 Million
2. Cowen Healthcare Royalty Partners Raises $1 Billion
3. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
4. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
5. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
6. AVANIR Pharmaceuticals To participate in two conferences in March
7. Favorable Scenario for Japan Pharma Industry in Coming Years, New Report Says
8. Hyperion Wins NDA Approval for UCD Drug Developed With Support from PharmaDirections
9. Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
10. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
11. Serialization in Pharmaceuticals, a Webinar Presented by Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Pfanstiehl has announced the launch of ... the USA under ICH ... for playing a key role in protein glycosylation.  ... that media supplementation with mannose can improve overall ... to Dr. Christopher Wilcox , VP, Business ...
(Date:10/1/2014)... CA (PRWEB) September 30, 2014 ... user-friendly, cost-effective tools to address sales, training and ... has developed innovative mobile applications to turn ... outlining the agency’s latest customized mobile app creations, ... http://www.studiopmg.com/work . , In partnership with Toyota, StudioPMG ...
(Date:10/1/2014)... Francisco, California (PRWEB) October 01, 2014 ... from the National Science Foundation to expand their bioCAD/CAM ... to build and modify DNA. The Small Business Innovation ... commercialize the “j5” technology under exclusive license from the ... Joint BioEnergy Institute , an LBNL laboratory that ...
(Date:9/30/2014)... available in German . ... quantum dots in a semiconductor layer. Quantum dots are small ... processes. If a short laser pulse is fired at the ... dot experiences a change in the electromagnetic field around it. ... of light by the dot. As soon as the refractive ...
Breaking Biology Technology:Pfanstiehl Launches cGMP-produced Mannose for Cell Culture Media Optimization & Glycoprotein Biosynthesis 2Digital Agency Studio PMG Launches New Case Studies on Website 2TeselaGen Receives $750k NSF SBIR Phase II Award 2TeselaGen Receives $750k NSF SBIR Phase II Award 3Ultrafast remote switching of light emission 2
... skills needed for the Information Age. Their administrations, as well ... way beyond the Industrial Age. , ,For the most ... not talking about reading, writing and `rithmetic; I am talking ... to regimentation, which is what was needed to assimilate people ...
... receive $1.5 million from the U.S. Department of Energy ... ethanol at paper mills by extracting the sugars from wood ... Akhtar, president of CleanTech Partners and principal investigator on the ... Other participants included the United States Department of Agriculture ...
... - The origins of Madison's technology industry can be ... isolated when he opened DNASTAR, Inc . that year. , ... - and a few more, the producer of DNA analysis ... era where it was considered bad form - even a social ...
Cached Biology Technology:Rote education fails the Information Age 2Rote education fails the Information Age 3Rote education fails the Information Age 4DNASTAR catches second wave of sequencing 2DNASTAR catches second wave of sequencing 3DNASTAR catches second wave of sequencing 4
(Date:10/1/2014)... TURKU , Finnland, October 1, 2014 ... der Durchbruch im Bereich der Biowissenschaften   ... Jahren ein Kommen und Gehen zahlreicher Detektionstechnologien. ... sich zum goldenen Standard. Die Photonen-Upconversion ist ... den letzten Jahren mit Begeisterung aufgenommen wurde. ...
(Date:9/30/2014)... effects of moorland burning is published today in the ... aim of relieving tensions on both sides of the ... of Moorland Burning on the Ecohydrology of River basins) ... is practised predominantly to support red grouse populations for ... peat chemistry and physical properties, river water chemistry and ...
(Date:9/30/2014)... seedless watermelon, salmon, and strawberries all have in common? ... sets of chromosomes and are diploid, these organisms are ... of chromosomesseedless watermelon and salmon have 3 and 4 ... While this might seem surprising, in fact most plant ... discovered over a century ago, but only recently, with ...
Breaking Biology News(10 mins):Innovative Verwendungslösung für die Photonen-Upconversion 2Innovative Verwendungslösung für die Photonen-Upconversion 3Grouse moor burning causes widespread environmental changes 2Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 2Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 3Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 4
... that has wiped out more than 100 species, scientists at ... species in Panama: Pristimantis educatoris , from Omar Torrijos ... near the Colombian border. , In 1989 researchers realized that ... cause: a fungal disease called chytridiomycosis. In 2004 Karen Lips, ...
... than two million miles of the nation,s ... nearing the end of its useful life, ... not attract much attention because of this ... professor of civil and environmental engineering (CEE). ...
... at Oregon State University have made an important fundamental advance ... not only can walk and run effectively, but use little ... with robotic mechanisms, studies are moving closer to robots that ... limbs for humans that work much better, or even help ...
Cached Biology News:2 new frog species discovered in Panama's fungal war zone 2Efforts underway at Virginia Tech to address deterioration of nation's water pipes 2Advances made in walking, running robots 2Advances made in walking, running robots 3
...
... Dr. P Set from different Cynomolgus ... More organs maybe available upon request. ... items from the whole set, and ... price. All Dr. P Set ...
...
Immunogen: Recombinant full length protein, corresponding to amino acids 1-435 of Human AP2M1. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: